SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOxford Instruments Regulatory News (OXIG)

Share Price Information for Oxford Instruments (OXIG)

Share Price is delayed by 15 minutes
Get Live Data
2,958.00    80.00 (2.78%)
Bid:
2,950.00
Ask:
2,956.00
Spread: 6.00 (0.203%)
Market Cap: £1.63b
OXIG Live PriceLast checked at - London Stock Exchange

Intraday Oxford Instruments Share Chart

Trading Statement

11 Apr 2019 07:00

RNS Number : 8302V
Oxford Instruments PLC
11 April 2019
 

 

 

Oxford Instruments plc

Trading Update 11 April 2019

 

Oxford Instruments plc, a leading provider of high technology products and services to industrial companies and scientific research communities, is today issuing a trading update.

 

As predicted, trading in the second half of the year was supported by a strong order book and our normal second half seasonal bias. We expect adjusted operating profit for the full year to be around the higher end of expectations1, despite a small adverse currency effect.

 

A good cash conversion during the year has resulted in the Group achieving a positive net cash position as at 31 March 2019.

 

Oxford Instruments' results for the year ended 31 March 2019 will be released on 11 June 2019.

 

 

 

1 Oxford Instruments compiled analyst forecast range for adjusted operating profit (year to 31 March 2019): £46.0m to £49.2m

 

 

Enquiries:

 

Oxford Instruments plc Tel: 01865 393200

Ian Barkshire, Chief Executive

Gavin Hill, Group Finance Director

 

MHP Communications Tel: 020 3128 8100

Rachel Hirst/Luke Briggs

 

 

 

- Ends -

Issued for and on behalf of Oxford Instruments plc

Notes to Editors  

 

About Oxford Instruments plc

Oxford Instruments designs, supplies and supports high-technology tools and systems with a focus on research and industrial applications. Innovation has been the driving force behind Oxford Instruments' growth and success for over 50 years, and its strategy is to effect the successful commercialisation of these ideas by bringing them to market in a timely and customer-focused fashion. 

 

The first technology business to be spun out from Oxford University, Oxford Instruments is now a global company and is listed on the London Stock Exchange (OXIG). Its objective is to be the leading provider of new generation tools and systems for the research and industrial sectors with a focus on nanotechnology. Its key market sectors include nano-fabrication and nano-materials. The company's strategy is to expand the business into the life sciences arena, where nanotechnology and biotechnology intersect.

 

This involves the combination of core technologies in areas such as low temperature and high magnetic field environments; Nuclear Magnetic Resonance; X-ray, electron, laser and optical based metrology; atomic force microscopy; optical imaging; advanced growth, deposition and etching.

 

Oxford Instruments aims to pursue responsible development and deeper understanding of our world through science and technology. Its products, expertise, and ideas address global issues such as energy, environment, security and health. 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTDBLFFKZFEBBE
Date   Source Headline
2nd Jan 201911:33 amPRNHolding(s) in Company
17th Dec 20181:22 pmPRNHolding(s) in Company
12th Dec 201810:25 amPRNDirector/PDMR Shareholding
11th Dec 20185:07 pmPRNHolding(s) in Company
10th Dec 20189:34 amPRNHolding(s) in Company
3rd Dec 20183:20 pmPRNHolding(s) in Company
28th Nov 20189:31 amPRNHolding(s) in Company
26th Nov 201810:17 amPRNAppointment of Chairman
22nd Nov 201810:26 amPRNHolding(s) in Company
13th Nov 20189:49 amPRNDirector/PDMR Shareholding
13th Nov 20187:00 amRNSHalf-year Report
11th Oct 201810:38 amPRNDirector/PDMR Shareholding
11th Sep 20184:07 pmPRNResult of AGM
11th Sep 20181:47 pmPRNDirector/PDMR Shareholding
11th Sep 20187:00 amRNSInterim Chairman's AGM Statement 2018
13th Aug 20183:27 pmPRNDirector/PDMR Shareholding
24th Jul 201812:00 pmPRNHolding(s) in Company
23rd Jul 20181:00 pmRNSDeath of Chairman
19th Jul 20187:00 amPRNHolding(s) in Company
11th Jul 201812:15 pmPRNHolding(s) in Company
11th Jul 201811:51 amPRNDirector/PDMR Shareholding
5th Jul 201811:09 amPRNBlocklisting - Interim Review
4th Jul 201812:02 pmPRNDirector/PDMR Shareholding
12th Jun 201810:46 amPRNDirector/PDMR Shareholding
12th Jun 20187:00 amRNSFinal Results
11th May 201812:07 pmPRNDirector/PDMR Shareholding
11th Apr 20187:00 amRNSTrading Update
9th Apr 201811:03 amPRNDirector/PDMR Shareholding
1st Mar 201812:35 pmPRNDirector/PDMR Shareholding
8th Feb 20189:36 amPRNDirector/PDMR Shareholding
1st Feb 201811:21 amPRNTotal Voting Rights
9th Jan 20189:59 amPRNBlocklisting - Interim Review
5th Dec 201710:43 amPRNTotal Voting Rights
16th Nov 20179:22 amPRNHolding(s) in Company
14th Nov 20177:00 amRNSHalf-year Report
31st Oct 201710:02 amPRNDirectorate Change
3rd Oct 201711:42 amPRNTotal Voting Rights
26th Sep 20172:02 pmPRNCorrection : Director/PDMR Shareholding
26th Sep 201710:57 amPRNDirector/PDMR Shareholding
12th Sep 201711:59 amPRNResult of AGM
12th Sep 20177:00 amRNSAGM Statement
4th Sep 201711:14 amPRNTotal Voting Rights
17th Aug 201710:26 amPRNHolding(s) in Company
8th Aug 201712:55 pmPRNTotal Voting Rights
4th Jul 201710:24 amPRNBlocklisting - Interim Review
4th Jul 201710:12 amPRNTotal Voting Rights
3rd Jul 20172:48 pmRNSCompletion of Sale of Industrial Analysis to HHT
13th Jun 20178:41 amRNSAppointment of Senior Independent Director
13th Jun 20177:03 amRNSAppointment of Senior Independent Director
13th Jun 20177:00 amRNSFinal Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.